Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Jan-24 8:37 PM View:  | Cytomx Therapeutics, Inc. (CTMX) | 18-Jan-24 | Grant | 26,250 | -- | -- | 100% 0 to 26.25K | |
| 19-Apr-23 4:07 PM View: | Fate Therapeutics Inc (FATE) | 18-Apr-23 | Sale | 2,532 | $6.57 | $16,647.70 | (2%) 143.21K to 140.68K | |
| 11-Jan-23 4:05 PM View: | Fate Therapeutics Inc (FATE) | 10-Jan-23 | Sale | 7,825 | $5.24 | $41,003.00 | (5%) 151.03K to 143.21K | |
| 21-Apr-22 4:04 PM View: | Fate Therapeutics Inc (FATE) | 19-Apr-22 | Sale | 4,062 | $35.37 | $143,673.00 | (3%) 155.09K to 151.03K | |
| 27-Jan-22 4:37 PM View: | Fate Therapeutics Inc (FATE) | 25-Jan-22 | Grant | 33,302 | -- | -- | 27% 121.79K to 155.09K | |
| 13-Jan-22 4:05 PM View: | Fate Therapeutics Inc (FATE) | 11-Jan-22 | Market Sale | 3,965 | $48.51 | $192,340.00 | (3%) 125.76K to 121.79K | (2%) |
| 13-Dec-21 5:53 PM View: | Fate Therapeutics Inc (FATE) | 10-Dec-21 | Option Exercise | 7,500 | $16.32 | $122,400.00 | 6% 125.76K to 133.26K | |
| 13-Dec-21 5:53 PM View: | Fate Therapeutics Inc (FATE) | 10-Dec-21 | Market Option Sale (Planned) | 7,500 | $51.46 | $385,948.00 | (6%) 133.26K to 125.76K | |
| 22-Nov-21 5:38 PM View: | Fate Therapeutics Inc (FATE) | 19-Nov-21 | Grant | 60,958 | -- | -- | 94% 64.8K to 125.76K | |
| 20-Apr-21 4:00 PM View: | Fate Therapeutics Inc (FATE) | 16-Apr-21 | Market Sale | 3,275 | $83.30 | $272,809.00 | (5%) 68.08K to 64.8K | 4% |